| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.0035 | 1 |